Nucleic Acid-Based Nanomaterials
Stabilities and Applications
1. Auflage Mai 2024
224 Seiten, Hardcover
1 Abbildungen (1 Farbabbildungen)
6 Tabellen
Handbuch/Nachschlagewerk
ISBN:
978-3-527-35205-0
Wiley-VCH, Weinheim
Kurzbeschreibung
comprehensively reviews the current research status, the biostability and diverse applications of nucleic acid nanomaterials.
Weitere Versionen
1. Introductions of Nucleic Acid-based Nanomaterials
2. The methods to Improve the Stability of Framework Nucleic Acid-based Nanomaterials
3. Framework Nucleic Acid-Based Nanomaterials: A Promising Vehicle for Small Molecular Cargos
4. The Application of Framework Nucleic Acid-Based Nanomaterials in the Treatment of Mitochondrial Dysfunction
5. Regeneration of Bone-related Diseases by Nucleic Acid-Based Nanomaterials: Perspectives from Tissue Regeneration and Molecular Medicine
6. In situ Fluorescence Imaging and Biotherapy of Tumor Based on Hybridization Chain Reaction
7. Application and Prospects of Framework Nucleic Acid-Based Nanomaterials in Tumor Therapy
8. Application of Framework Nucleic Acid-Based Nanomaterials in the Treatment of Endocrine and Metabolic Diseases
9. The Antibacterial Applications of Framework Nucleic Acid-Based Nanomaterials: Current Progress and Further Perspectives
10. Framework Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects
2. The methods to Improve the Stability of Framework Nucleic Acid-based Nanomaterials
3. Framework Nucleic Acid-Based Nanomaterials: A Promising Vehicle for Small Molecular Cargos
4. The Application of Framework Nucleic Acid-Based Nanomaterials in the Treatment of Mitochondrial Dysfunction
5. Regeneration of Bone-related Diseases by Nucleic Acid-Based Nanomaterials: Perspectives from Tissue Regeneration and Molecular Medicine
6. In situ Fluorescence Imaging and Biotherapy of Tumor Based on Hybridization Chain Reaction
7. Application and Prospects of Framework Nucleic Acid-Based Nanomaterials in Tumor Therapy
8. Application of Framework Nucleic Acid-Based Nanomaterials in the Treatment of Endocrine and Metabolic Diseases
9. The Antibacterial Applications of Framework Nucleic Acid-Based Nanomaterials: Current Progress and Further Perspectives
10. Framework Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects
Yunfeng Lin obtains his B.D. and Ph.D. from Sichuan University in 2001 and 2006. He joined the West China College of Stomatology, Sichuan University at 2006 and became the full professor of Sichuan University since 2008. He took his postdoctoral research at Harvard University between 2009 and 2010. He is Vice-director of West China Medical Center, Sichuan University and Vice-director of State Key Laboratory of Oral Diseases. His main research focus on Stem Cell Biology, DNA Nanomaterial and Tissue Regeneration. He has published over 178 SCI papers as corresponding author or first author, including Nature Protocols, Materials Today, Advanced Materials et al. His papers have been cited for more than 7700 times. He has edit 8 English books. He received National High-level personnel of special support program of China, Young Scientific and Technological Innovation Leader of China, Chinese Youth Science and Technology Award, Ministry of Education Science and Technology Progress Award, New Century Excellent Talents of Chinese Ministry of Education and National Excellent Doctoral Dissertation of China.
Shaojingya Gao earned his M.Sc. (2019) and Ph.D. (2022) degrees from West China Collage of Stomatology in Sichuan University. Since 2019, she joined Prof. Yunfeng Lin group as a postdoctoral researcher in State Key Laboratory of Oral Diseases. She has published more than 10 papers in scientific journals. Currently, her research interests focus on the immunotherapy and drug delivery of framework nucleic acids.
Shaojingya Gao earned his M.Sc. (2019) and Ph.D. (2022) degrees from West China Collage of Stomatology in Sichuan University. Since 2019, she joined Prof. Yunfeng Lin group as a postdoctoral researcher in State Key Laboratory of Oral Diseases. She has published more than 10 papers in scientific journals. Currently, her research interests focus on the immunotherapy and drug delivery of framework nucleic acids.
